¡Sorpréndeme!
Laurus Labs Forays Into Biotech Segment Via Acquisition
2022-02-25
2
Dailymotion
Videos relacionados
Laurus Labs In Focus | Ask Profit | NDTV Profit
Laurus Labs Awaits U.S. FDA Inspection Next Month, CEO Says
Laurus Labs In Focus | Ask Profit | NDTV Profit
Ideas for Profit | Laurus Labs - a diversified portfolio of APIs and formulations.
Q4 Review: Laurus Labs' Plans To Accelerate Growth In FY23
Laurus Labs Management On Q1 Report Card & More
Talking Point With Laurus Labs' Satyanarayana Chava
Laurus Labs In Focus | Profit Insight | NDTV Profit
Margins Lower On R&D Spends: Laurus Labs
Laurus Labs' Management Shares Outlook For Q4 & Beyond
